These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A novel therapeutic strategy against vascular disorders with chymase inhibitor. Takai S; Miyazaki M Curr Vasc Pharmacol; 2003 Jun; 1(2):217-24. PubMed ID: 15320845 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related]
24. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I. Roks A; Buikema H; Pinto YM; van Gilst WH Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561 [TBL] [Abstract][Full Text] [Related]
25. The chymase-angiotensin system in humans. Husain A J Hypertens; 1993 Nov; 11(11):1155-9. PubMed ID: 8301095 [No Abstract] [Full Text] [Related]
26. Role of chymase on vascular proliferation. Miyazaki M; Takai S J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):23-6. PubMed ID: 11967791 [TBL] [Abstract][Full Text] [Related]
27. Progression of cardiovascular damage: the role of renin-angiotensin system blockade. Probstfield JL; O'Brien KD Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969 [TBL] [Abstract][Full Text] [Related]
28. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
29. [The future of renin inhibition]. Uresin AY; Baran E Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475 [TBL] [Abstract][Full Text] [Related]
30. The physiological significance of the alternative pathways of angiotensin II production. Kramkowski K; Mogielnicki A; Buczko W J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979 [TBL] [Abstract][Full Text] [Related]
31. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart. Katugampola SD; Davenport AP Clin Sci (Lond); 2002 Jan; 102(1):15-21. PubMed ID: 11749656 [TBL] [Abstract][Full Text] [Related]
32. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias. Garg S; Narula J; Marelli C; Cesario D Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603 [TBL] [Abstract][Full Text] [Related]
33. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET? Ram CV; Deedwania PC Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307 [No Abstract] [Full Text] [Related]
34. Angiotensin receptor blockers: novel role in high-risk patients. Javed U; Deedwania PC Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228 [TBL] [Abstract][Full Text] [Related]
35. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure. Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843 [TBL] [Abstract][Full Text] [Related]
36. [Angiotensin II antagonists: a promising pathway]. Cohen-Solal A Arch Mal Coeur Vaiss; 2000 Jun; Spec No():10-1, 15. PubMed ID: 10949700 [No Abstract] [Full Text] [Related]
37. Angiotensin converting enzyme-independent angiotensin ii production by chymase is up-regulated in the ischemic kidney in renovascular hypertension. Sadjadi J; Kramer GL; Yu CH; Burress Welborn M; Chappell MC; Gregory Modrall J J Surg Res; 2005 Aug; 127(2):65-9. PubMed ID: 15869764 [TBL] [Abstract][Full Text] [Related]
38. Alternative pathways of angiotensin II production in the human saphenous vein. Borland JA; Chester AH; Morrison KA; Yacoub MH Br J Pharmacol; 1998 Oct; 125(3):423-8. PubMed ID: 9806322 [TBL] [Abstract][Full Text] [Related]
39. Assessment of the angiotensin II-forming pathway in human atria. Ohmichi N; Iwai N; Shimoike H; Izumi M; Watarida S; Mori A; Nakamura Y; Kinoshita M Heart Vessels; 1997; Suppl 12():116-8. PubMed ID: 9476560 [TBL] [Abstract][Full Text] [Related]
40. [Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases]. Mitsuyama K Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):176-7. PubMed ID: 18350678 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]